Tryptophan becomes serotonin through a two-step enzymatic process: first, the enzyme tryptophan hydroxylase converts tryptophan into an intermediate called 5-hydroxytryptophan (5-HTP), and then a second enzyme strips off a chemical group to produce serotonin. That first step, the hydroxylation, is the bottleneck that controls how much serotonin your body can make at any given moment. But the pathway is shaped by far more than just those two reactions. Where in the body the conversion happens, which version of the enzyme does the work, what cofactors are available, and whether competing pathways are draining tryptophan all determine how much serotonin you end up with.
The Two-Step Conversion
Tryptophan is one of the amino acids you get from food. Your body cannot manufacture it, so the supply depends entirely on what you eat. Once tryptophan enters a cell equipped with the right machinery, the enzyme tryptophan hydroxylase (TPH) adds a hydroxyl group to it, producing 5-HTP. This is the rate-limiting step, meaning it is the slowest part of the chain and therefore the step that sets the overall pace of serotonin production.1PubMed Central. 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology Everything upstream and downstream moves faster than this one reaction, so the availability and activity of TPH largely dictates serotonin output.
The second step happens almost immediately. An enzyme called aromatic L-amino acid decarboxylase (often shortened to AADC) removes a carboxyl group from 5-HTP, yielding serotonin. AADC is abundant and fast, so 5-HTP rarely accumulates. Under normal conditions, any 5-HTP produced is converted to serotonin within moments. This is why, when researchers or supplement makers want to boost serotonin, they often focus on that first bottleneck rather than the second step.
TPH requires a cofactor to function: tetrahydrobiopterin, usually called BH4. Without BH4, tryptophan hydroxylase cannot catalyze the reaction. BH4 is also needed for the production of dopamine and nitric oxide, which means the same cofactor feeds several important signaling systems at once.2PubMed Central. Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry Conditions that deplete BH4 can therefore affect not just serotonin but multiple brain chemicals simultaneously. Iron and vitamin B6 also participate in the pathway, with B6 serving as a cofactor for the AADC step.
Two Enzyme Systems, Two Serotonin Pools
For decades, scientists assumed there was a single tryptophan hydroxylase gene. It was not until 2003 that a second isoform was identified, revealing that the body runs two largely separate serotonin production systems. TPH1 operates primarily in peripheral tissues, especially the gut’s enterochromaffin cells and the pineal gland. TPH2 works in the brain, particularly in the raphe nuclei of the brainstem, which are the central hub for serotonin-producing neurons.3PubMed. Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland
The two enzymes are not interchangeable. TPH2 is more soluble, has a higher molecular weight, and behaves differently under regulation by cellular signaling molecules. TPH2 is phosphorylated at a site that does not even exist on TPH1, which means the brain can fine-tune serotonin production using control switches that have no effect on gut serotonin.4PubMed. Different properties of the central and peripheral forms of human tryptophan hydroxylase This distinction matters because about 95 percent of the body’s serotonin is made in the gut, not the brain, and the two pools serve very different functions.
Experiments with genetically engineered mice confirm the separation cleanly. Knocking out TPH1 dramatically reduced serotonin in blood and intestinal tissue but left brain serotonin essentially untouched. Knocking out TPH2 disrupted brain serotonin without significantly altering peripheral levels.5PLOS ONE. Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants Only when both genes were knocked out did serotonin collapse everywhere. This means a drug or condition that targets one isoform can reshape serotonin signaling in one compartment while leaving the other relatively intact.
Getting Tryptophan Into the Brain
Before TPH2 can make serotonin in the brain, tryptophan has to cross the blood-brain barrier. It does so via a transporter called the large neutral amino acid transporter (LAT1), which it shares with several other amino acids including leucine, isoleucine, valine, phenylalanine, and tyrosine.6PubMed. Selective expression of the large neutral amino acid transporter at the blood-brain barrier Think of it as a ferry with limited seats: tryptophan competes with these other amino acids for a ride across. If your blood has a high ratio of competing amino acids relative to tryptophan, less tryptophan reaches the brain and serotonin production slows down.
This is where the popular idea that eating turkey makes you sleepy falls apart. Turkey does contain tryptophan, but so does virtually any protein-rich food, and those foods also deliver large amounts of the competing amino acids. A high-protein meal actually tends to lower the tryptophan-to-competitor ratio in your blood, which can reduce brain tryptophan uptake rather than increase it. Carbohydrate-rich meals trigger insulin, which pulls competing amino acids into muscle tissue and thereby gives tryptophan a relative advantage at the transporter. But the effect requires protein intake to be very low, making the mechanism largely irrelevant under normal dietary conditions.7PubMed Central. Carbohydrate and sleep: An evaluation of putative mechanisms
The Kynurenine Detour
Serotonin synthesis is not the only thing your body can do with tryptophan. In fact, most dietary tryptophan never becomes serotonin. The majority is funneled into the kynurenine pathway, a separate metabolic route that produces a range of biologically active compounds, some neuroprotective and some neurotoxic. Two enzymes, tryptophan 2,3-dioxygenase (TDO) in the liver and kidneys, and indoleamine 2,3-dioxygenase (IDO) in many tissues including the brain, catalyze the first and rate-limiting step of this competing pathway.8PubMed. Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway
Under normal circumstances, TDO handles most of the kynurenine work. But during inflammation, IDO gets dramatically upregulated. Inflammatory signals such as interferon-gamma can ramp up IDO activity in immune cells and other tissues, effectively siphoning tryptophan away from serotonin production and toward kynurenine metabolites.9PubMed Central. Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation This diversion has real consequences. Studies of human placental tissue exposed to bacterial and viral mimics found that infection increased IDO activity and gene expression while simultaneously reducing serotonin output, creating an imbalance between neurotoxic and neuroprotective kynurenine metabolites.10PubMed Central. Pathological shifts in tryptophan metabolism in human term placenta exposed to LPS or poly I:C
This tug-of-war between the serotonin and kynurenine pathways is one reason chronic inflammation is so strongly linked to mood disorders. When the immune system is persistently activated, tryptophan gets consumed by the kynurenine route, potentially starving the serotonin pathway of its raw material. The end products of the kynurenine pathway include quinolinic acid, which is neurotoxic at high concentrations, compounding the problem beyond just low serotonin.
Gut Serotonin and the Microbiome
Most of the serotonin in your body is made by enterochromaffin cells scattered along the lining of the gut. These specialized cells act as chemical sensors, detecting what is passing through the intestine and translating those cues into serotonin release.11PubMed Central. Interleukin-33 Promotes Serotonin Release from Enterochromaffin Cells for Intestinal Homeostasis Gut serotonin regulates motility (how fast food moves through), secretion, and sensory signaling in the intestine. It also enters the bloodstream, where platelets scoop it up and store it in dense granules for use in blood clotting and wound healing.
Your gut bacteria play a surprisingly active role in this process. Microbial metabolites, particularly short-chain fatty acids like butyrate, propionate, and acetate that are produced when bacteria ferment dietary fiber, stimulate enterochromaffin cells to ramp up serotonin production. They do this by increasing expression of TPH1, the rate-limiting enzyme for gut serotonin synthesis.12PubMed Central. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells Mice raised in germ-free environments, with no gut bacteria at all, had substantially lower colonic serotonin compared to conventionally raised mice. When researchers introduced normal gut microbiota back into germ-free mice, colonic serotonin levels rose significantly.12PubMed Central. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells
A common misconception is that gut serotonin directly affects mood. Serotonin does not cross the blood-brain barrier, so the large pool in your intestines and bloodstream cannot reach the brain’s serotonin circuits. Brain serotonin depends on local TPH2 activity and the tryptophan that makes it across the barrier. That said, gut serotonin is far from irrelevant to overall health: it influences digestion, immune signaling, bone density, and cardiovascular function through its own set of receptors and through platelets.
Platelets and Serotonin Storage
Platelets cannot make serotonin themselves. Instead, they absorb it from the blood plasma using the same serotonin transporter (SERT) that neurons use, and store it in dense granules. When a platelet is activated at a wound site, it releases that stored serotonin, which helps constrict blood vessels and promotes clot formation.13IntechOpen. Immuno-Thrombotic Effects of Platelet Serotonin This is one reason that drugs targeting SERT, including SSRIs, can affect bleeding and bruising. By blocking the transporter, these medications reduce the amount of serotonin platelets can absorb, which in turn impairs their contribution to clotting.
From Serotonin to Melatonin
Serotonin is not the end of the metabolic line. In the pineal gland, serotonin is converted into melatonin through two more enzymatic steps. First, serotonin N-acetyltransferase (known as AANAT) adds an acetyl group to serotonin, producing N-acetylserotonin. Then a second enzyme, hydroxyindole-O-methyltransferase (HIOMT), converts that intermediate into melatonin.14Molecular Cell. Melatonin Biosynthesis: The Structure of Serotonin N-Acetyltransferase at 2.5 Å Resolution Suggests a Catalytic Mechanism AANAT activity is tightly controlled by the light-dark cycle, rising sharply at night and dropping during the day, which is why melatonin production follows a circadian rhythm.
This means the tryptophan pathway does not stop at serotonin. It extends all the way to the hormone that regulates your sleep-wake cycle. A shortfall at any upstream step, whether from low tryptophan availability, reduced TPH activity, or diversion of tryptophan into the kynurenine pathway, can cascade downstream to affect not just mood but also sleep architecture.
The Receptor Landscape
Once serotonin is released, it acts on an unusually large family of receptors. There are seven subfamilies of serotonin receptors, encompassing at least 13 distinct genes. When you include variants created by alternative splicing and RNA editing, the number of functionally distinct serotonin receptors climbs to at least 30.15Pharmacology & Therapeutics. Multiplicity of mechanisms of serotonin receptor signal transduction This diversity explains why serotonin can do so many seemingly contradictory things: constrict blood vessels in one tissue, relax smooth muscle in another, suppress appetite through one receptor subtype, and trigger nausea through a different one. The effects of serotonin depend less on the molecule itself than on which receptor catches it and what cell that receptor sits on.
Serotonylation, a Newer Discovery
Beyond binding to receptors on the cell surface, serotonin can be covalently attached to proteins inside cells in a process called serotonylation. Enzymes called transglutaminases, particularly TG2, catalyze this bond, linking serotonin to specific sites on target proteins. The discovery is not actually that new, it was first observed over 60 years ago, but understanding what serotonylation does is still catching up.16PubMed Central. Serotonylation: Serotonin Signaling and Epigenetics
Early targets identified were small G-proteins in platelets, where serotonylation plays a role in platelet aggregation and clot formation. The same modification has been implicated in insulin secretion from pancreatic cells and in the proliferation of smooth muscle cells in pulmonary blood vessels, linking it to pulmonary arterial hypertension.16PubMed Central. Serotonylation: Serotonin Signaling and Epigenetics More recently, researchers found that histones, the proteins around which DNA is wound, can be serotonylated. This opens a genuinely new dimension: serotonin may influence gene expression itself, not just by triggering receptor cascades but by physically modifying the proteins that control how DNA is read.17PubMed Central. Beyond neurotransmission: the roles of serotonylation in physiological and pathological processes Research into serotonylation’s role in neurodegenerative conditions, including Alzheimer’s disease, is still in early stages but has attracted growing attention.18PubMed Central. Role of Serotonylation and SERT Posttranslational Modifications in Alzheimer’s Disease Pathogenesis
Genetic Variation in TPH2
Not everyone runs this pathway at the same speed. Genetic variants in the TPH2 gene can meaningfully alter how much serotonin the brain produces. One well-studied example is a coding variant that swaps a serine for a tyrosine at a specific position in the TPH2 protein. In cell culture experiments, the variant allele produced roughly 36 percent less serotonin than the normal version.19JAMA Psychiatry. Association of Functional Polymorphisms of the Human Tryptophan Hydroxylase 2 Gene With Risk for Bipolar Disorder in Han Chinese The affected position is highly conserved across species from zebrafish to humans, suggesting it matters for normal enzyme function. Variants like this have been investigated as risk factors for mood disorders, though a single polymorphism rarely acts alone.
What 5-HTP Supplements Actually Do
Because the TPH step is the bottleneck, supplementing with 5-HTP effectively bypasses it. When you take 5-HTP orally, it enters the bloodstream and can be converted directly to serotonin by AADC, which is widely distributed throughout the body. However, this creates a problem: much of the 5-HTP is converted to serotonin in the periphery before it ever reaches the brain. The amount of 5-HTP that makes it to the central nervous system depends heavily on how much peripheral conversion occurs along the way.20Pharmacology & Therapeutics. Serotonin a la carte: Supplementation with the serotonin precursor 5-hydroxytryptophan
Peripheral decarboxylase inhibitors like carbidopa, which are sometimes co-administered in clinical settings, can block this premature conversion and allow more 5-HTP to cross the blood-brain barrier intact.20Pharmacology & Therapeutics. Serotonin a la carte: Supplementation with the serotonin precursor 5-hydroxytryptophan Over-the-counter 5-HTP supplements do not include such inhibitors, so the fraction that actually influences brain serotonin is uncertain and likely variable from person to person. Meanwhile, the serotonin produced in the periphery from supplemental 5-HTP can potentially affect gut motility and platelet function, which is worth keeping in mind for anyone taking these supplements alongside serotonergic medications.
Tryptophan Depletion as a Research Window
Much of what we know about serotonin’s role in human mood and cognition comes from a technique called acute tryptophan depletion. Researchers give participants a drink loaded with large neutral amino acids but lacking tryptophan. The competing amino acids flood the transporter at the blood-brain barrier, effectively starving the brain of tryptophan for several hours. Brain serotonin synthesis drops measurably during this window, providing a temporary, reversible way to study what low serotonin does to mood, memory, and behavior.21PubMed Central. Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects Animal studies have confirmed that the method effectively and specifically suppresses central serotonin function.22PLOS ONE. Effects of Acute Tryptophan Depletion on Brain Serotonin Function and Concentrations of Dopamine and Norepinephrine in C57BL/6J and BALB/cJ Mice
The findings from tryptophan depletion studies have been a mix of clarity and confusion. Healthy people who have never had depression generally do not feel much worse during depletion, while people who have recovered from depression on serotonergic medications are more likely to experience a temporary return of low mood. This has led to the understanding that serotonin’s role in depression is less about a simple deficiency and more about vulnerability in people whose systems are already sensitized.
An Ancient and Conserved System
The core components of the tryptophan-to-serotonin pathway are remarkably old. Tryptophan-based signaling molecules, including serotonin and its downstream product melatonin, appear in single-celled organisms, where they participate in cell division, differentiation, and survival. As multicellular life evolved, serotonin’s roles expanded and its concentrations rose dramatically, particularly in plants, where it serves functions ranging from growth regulation to defense against pathogens.23Handbook of Behavioral Neuroscience. Evolution of Serotonin: Sunlight to Suicide The deep evolutionary conservation of this pathway helps explain why serotonin shows up in so many seemingly unrelated biological roles, from gut motility and blood clotting in humans to root growth in plants. It was not designed for mood. It was repurposed, over and over, as organisms grew more complex, and the brain co-opted it relatively late in evolutionary time.